Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel chiral phosphoric acid catalysis enables high-yield indolocyclopentanes production with enhanced supply chain reliability for pharmaceutical intermediates manufacturing.
Novel iodine-promoted method for 3,4,5-trisubstituted 1,2,4-triazoles offers cost-effective, scalable routes for API intermediates without heavy metals.
Novel palladium-catalyzed route offers mild conditions and significant cost reduction in pharmaceutical intermediate manufacturing for global supply chains and strategic partners.
Patent CN113735756A details a high-yield Rh-catalyzed method for chiral 3,3-disubstituted isoindolinones, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel asymmetric oxidative coupling method for chiral spiro indolones using cinchona catalysts. High yield, mild conditions, scalable manufacturing for pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation method for 2-CF3 quinazolinones. High yield, scalable route for API intermediates like Rutaecarpine.
Novel silver oxide promoted method for high purity imidazole intermediates. Cost effective scalable process ensuring supply chain reliability.
Patent CN115637454A reveals a green electrochemical route for tetrahydroimidazo[1,5-a]quinoxalin-4(5H)-one derivatives, offering cost-effective API intermediate manufacturing.
Novel iodine-catalyzed method for C3-alkylated indoles offers metal-free green synthesis and cost-effective supply chain solutions for pharmaceutical intermediates.
Patent CN111675662B reveals a novel iron-catalyzed route for 2-trifluoromethyl quinazolinones, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN107501158A reveals a palladium-catalyzed route for indole derivatives. Achieve cost reduction in fine chemical manufacturing with scalable, high-purity intermediates.
Patent CN112480015B reveals a novel one-pot Pd-catalyzed method for synthesizing 2-trifluoromethyl quinazolinones, offering significant cost reduction in API manufacturing and high purity.
Patent CN110467579B discloses a novel iodine-promoted synthesis of 5-trifluoromethyl-1,2,4-triazoles, offering a cost-effective, metal-free route for pharmaceutical intermediates.
Patent CN102120731A reveals a novel, high-yield route for Gefitinib intermediates, offering significant cost reduction and simplified purification for pharmaceutical manufacturing.
Patent CN107522645B details a novel ruthenium-catalyzed [3+2] cycloaddition for polysubstituted pyrroles. This method offers mild conditions and broad substrate scope for pharmaceutical intermediates.
Novel metal-free route for azaspiro compounds offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally ensuring high purity standards.
Novel Pd-catalyzed tandem cyclization for quinofuran compounds. High atom economy, mild conditions, scalable route for pharma intermediates.
Novel silver oxide promoted method for 5-trifluoromethyl imidazole. Offers scalable, cost-effective pharmaceutical intermediate manufacturing with high yield and purity.
Patent CN118619879A reveals Rh-catalyzed synthesis. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN115215810B reveals catalyst-free synthesis for high-purity triazoles. Discover cost reduction and supply chain advantages for pharmaceutical intermediates manufacturing.